Advertisement
Screener

PHARMACYTE BIOTECH, INC. (PMCB) Graph

PMCB Revenue Flow

Filed revenue amounts for 2026-05-01 to 2026-07-31. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-07-31: Revenue $0.00; Cost of revenue (m); Research and development $60.00K; Operating expenses $1.01M.
  • 2026-04-30: Revenue $0.00*; Cost of revenue (m); Research and development $61.95K*; Operating expenses $2.51M*.
  • 2026-01-31: Revenue $0.00; Cost of revenue (m); Research and development $93.11K; Operating expenses $2.12M.
  • 2025-10-31: Revenue $0.00; Cost of revenue (m); Research and development $141.09K; Operating expenses $1.38M.

Revenue flow

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

PMCB revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Revenue$0.00Operating expenses$1.01MOperating income-$1.01MOther income, net-$97.00Research & development$60.00KIncome tax$0.00Net income-$5.08M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2026-07-31$0.00(m)$60.00K$1.01M$0.00-$5.08M
2026-04-30$0.00*(m)$61.95K*$2.51M*(m)-$4.39M*
2026-01-31$0.00(m)$93.11K$2.12M(m)$746.86K
2025-10-31$0.00(m)$141.09K$1.38M(m)-$7.42M
2025-07-31$0.00(m)$95.16K$848.30K$0.00-$8.36M
2025-01-31$0.00(m)$118.20K$960.25K(m)-$3.05M
2024-10-31$0.00(m)$97.47K$1.11M(m)-$1.47M
2024-07-31$0.00(m)$96.02K$1.27M(m)$23.42M
2024-01-31$0.00(m)$126.73K$1.87M(m)-$619.54K
2023-10-31$0.00(m)$82.03K$1.41M(m)$2.79M
2023-07-31$0.00(m)$104.48K$2.08M(m)-$3.18M
2023-01-31$0.00(m)$45.39K$1.55M(m)-$764.14K
2022-10-31$0.00(m)$178.00K$2.32M(m)-$1.88M
2022-07-31$0.00(m)$159.27K$1.68M(m)-$1.55M
2022-01-31$0.00(m)$158.04K$856.12K(m)-$811.29K
2021-10-31$0.00(m)$135.22K$1.00M(m)-$979.75K
2021-07-31$0.00(m)$143.61K$1.02M(m)-$1.03M
2021-01-31$0.00(m)$174.09K$756.85K(m)-$757.10K
2020-10-31$0.00(m)$151.31K$949.51K(m)-$950.19K
2020-07-31$0.00(m)$270.57K$881.68K(m)-$883.94K
2020-01-31$0.00(m)$113.30K$875.31K(m)-$875.31K
2019-10-31$0.00(m)$17.94K$1.07M(m)-$1.07M
2019-07-31$0.00(m)$72.33K$1.13M$0.00-$1.13M
2019-01-31$0.00(m)$59.14K$676.35K(m)-$676.35K
2018-10-31$0.00(m)$115.10K$1.04M(m)-$1.04M
2018-07-31$0.00(m)$267.79K$1.22M$0.00-$1.22M
2018-01-31$0.00(m)$802.56K$2.03M(m)-$2.03M
2017-10-31$0.00(m)$515.46K$1.81M(m)-$1.81M
2017-07-31$0.00(m)$427.67K$1.69M(m)-$1.69M
2017-04-30$0.00$0.00(m)$1.15M(m)-$1.16M
2017-01-31$0.00$0.00$579.72K$1.28M(m)-$1.28M
2016-10-31$0.00$0.00$253.77K$974.20K(m)-$974.55K
2016-07-31$0.00$0.00$175.00K$1.03M(m)-$1.03M
2016-04-30$0.00$0.00(m)$1.13M(m)-$1.12M
2016-01-31$0.00$0.00$573.98K$1.79M$0.00-$1.79M
2015-10-31$0.00$0.00$439.71K$1.64M(m)-$1.64M
2015-07-31$0.00$0.00$155.68K$1.51M(m)-$1.52M
2015-04-30$0.00$0.00(m)$4.02M(m)-$4.02M
2015-01-31$0.00$0.00$273.80K$1.46M(m)-$1.46M
2014-10-31$0.00$0.00$347.76K$6.20M(m)-$2.86M
2014-07-31$0.00$0.00$0.00$1.58M(m)-$1.58M
2014-04-30$0.00$0.00(m)$16.45M(m)-$16.47M
2014-01-31$0.00$0.00$0.00$681.08K(m)-$458.77K
2013-10-31$0.00$0.00$0.00$448.57K(m)-$5.66M
2013-07-31$0.00$0.00(m)$1.40M(m)-$4.67M
2013-01-31$0.00$0.00(m)$340.84K(m)-$376.84K
2012-10-31$6.29K$9.62K(m)$345.46K(m)-$382.82K
2012-07-31$6.63K$0.00(m)$545.41K(m)-$510.52K
2012-01-31$20.27K$2.21K(m)$428.04K(m)-$271.78K
2011-10-31$19.84K$6.04K(m)$417.54K(m)-$437.15K
2011-07-31$19.76K$15.68K(m)$656.69K(m)-$686.02K
2011-01-31$32.02K$21.98K(m)$78.82K(m)-$124.10K
2010-10-31$15.87K$2.85K(m)$32.19K(m)-$45.82K
2010-07-31$26.96K$6.93K(m)$99.37K(m)-$134.26K

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2025-10-31$0.00(m)$236.24K$2.22M(m)-$15.78M
2024-10-31$0.00(m)$193.49K$2.37M(m)$21.95M
2023-10-31$0.00(m)$186.52K$3.48M(m)-$393.40K
2022-10-31$0.00(m)$337.27K$4.00M(m)-$3.43M
2021-10-31$0.00(m)$278.83K$2.03M$1.60K-$2.01M
2020-10-31$0.00(m)$421.89K$1.83M$800.00-$1.83M
2019-10-31$0.00(m)$90.27K$2.20M(m)-$2.20M
2018-10-31$0.00(m)$382.89K$2.25M(m)-$2.25M
2017-10-31$0.00(m)$943.13K$3.50M(m)-$3.50M
2016-10-31$0.00$0.00$428.77K$2.01M(m)-$2.01M
2015-10-31$0.00$0.00$595.39K$3.15M(m)-$3.15M
2014-10-31$0.00$0.00$347.76K$7.83M(m)-$5.65M
2013-10-31$0.00$0.00$0.00$1.85M(m)-$10.32M
2012-10-31$12.91K$9.62K(m)$890.88K(m)-$893.33K
2011-10-31$39.61K$21.71K(m)$1.07M(m)-$1.12M
2010-10-31$42.83K$9.78K(m)$131.56K(m)-$180.08K

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-01-31$0.00(m)$329.36K(m)$4.34M(m)-$15.03M
2025-01-31$0.00(m)$311.68K(m)$3.34M(m)$18.91M
2024-01-31$0.00(m)$313.25K(m)$5.35M(m)-$1.01M
2023-01-31$0.00(m)$382.66K(m)$5.55M(m)-$4.19M
2022-01-31$0.00(m)$436.87K(m)$2.88M$1.60K-$2.82M
2021-01-31$0.00(m)$595.98K(m)$2.59M$800.00-$2.59M
2020-01-31$0.00(m)$203.57K(m)$3.08M(m)-$3.08M
2019-01-31$0.00(m)$442.04K(m)$2.93M(m)-$2.93M
2018-01-31$0.00(m)$1.75M(m)$5.53M(m)-$5.53M
2017-01-31$0.00$0.00$1.01M(m)$3.29M(m)-$3.29M
2016-01-31$0.00$0.00$1.17M(m)$4.94M$0.00-$4.94M
2015-01-31$0.00$0.00$621.57K$100.00K$9.29M(m)-$7.11M
2014-01-31$0.00$0.00$0.00(m)$2.53M(m)-$10.78M
2013-01-31$12.16K$9.62K(m)(m)$1.23M(m)-$1.27M
2012-01-31$59.88K$23.92K(m)(m)$1.50M(m)-$1.39M
2011-01-31$74.85K$31.76K(m)(m)$210.38K(m)-$304.18K

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2026-04-30$0.00(m)$391.30K$6.85M$0.00-$19.42M
2025-04-30$0.00(m)$438.42K$4.38M$0.00$30.66M
2024-04-30$0.00(m)$407.43K$8.52M$0.00$333.76K
2023-04-30$0.00(m)$468.54K$6.46M$0.00-$4.32M
2022-04-30$0.00(m)$690.94K$4.39M$0.00-$4.24M
2021-04-30$0.00(m)$916.25K$3.62M$0.00-$3.55M
2020-04-30$0.00(m)$301.22K$3.83M$0.00-$3.83M
2019-04-30$0.00(m)$460.05K$4.10M$0.00-$4.07M
2018-04-30$0.00(m)$2.00M$6.98M$0.00-$6.83M
2017-04-30$0.00(m)$1.18M$4.44M$0.00-$4.44M
2016-04-30$0.00$0.00$1.41M$6.07M$0.00-$6.06M
2015-04-30$0.00$0.00$3.48M$13.26M$0.00-$9.93M
2014-04-30$0.00$0.00$323.50K$18.98M$0.00-$27.25M
2013-04-30$12.16K$9.62K$0.00$1.69M$0.00-$1.60M
2012-04-30$66.56K$19.38K(m)$2.00M(m)-$1.90M
2011-04-30(m)$32.10K(m)$482.25K(m)-$1.40M

Similar stocks

Stock NameCountryMarket CapPE Ratio
AIM ImmunoTech Inc. (AIM)United States$0.006B
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
VivoSim Labs, INC. (VIVS)United States$0.003B
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
CURIS INC (CRIS)United States$0.002B-0.05
Silexion Therapeutics Corp (SLXN)$0.001B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70